Evidence map›Paper›PMID 36318340›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.

Hironobu Hata, Kenji Imamachi, Michihiro Ueda, Masashi Matsuzaka, Hiroaki Hiraga, Toshihisa Osanai, Toru Harabayashi, Katsuya Fujimoto, Satoshi Oizumi, Masato Takahashi and 4 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Hironobu HataDepartment of Dentistry and Oral Surgery, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan. hatabooh@gmail.com.ORCID http://orcid.org/0000-0002-0077-7026
Kenji ImamachiDepartment of Dentistry and Oral Surgery, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.ORCID http://orcid.org/0000-0003-1090-3660
Michihiro UedaDepartment of Clinical Oral Oncology, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Masashi MatsuzakaClinical Research Support Centre, Hirosaki University Hospital, 53 Honcho, Hirosaki, 036-8563, Japan.ORCID http://orcid.org/0000-0002-8199-3037
Hiroaki HiragaDepartment of Orthopaedic Surgery, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Toshihisa OsanaiDepartment of Rehabilitation, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.ORCID http://orcid.org/0000-0003-0220-0535
Toru HarabayashiDepartment of Urology, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Katsuya FujimotoDepartment of Hematology, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Satoshi OizumiDepartment of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Masato TakahashiDepartment of Breast Surgery, Division of Surgery, Hokkaido University Graduate School of Medicine, Nishi 5-Tyoume Kita 14-Jyo, Kita-Ku, Sapporo, 060-8648, Japan.ORCID http://orcid.org/0000-0002-6641-9598
Kazuhito YoshikawaDepartment of Dentistry and Oral Surgery, National Hospital Organization Hokkaido Cancer Center, 3-54 Kikusui 4-Jyo 2-Tyoume, Shiroishi-Ku, Sapporo, 003-0804, Japan.
Jun SatoDepartment of Oral Pathobiological Science, Faculty of Dental Medicine, Oral Diagnosis and Medicine, Hokkaido University, Nishi 7-Tyoume Kita 13-Jyo, Kita-Ku, Sapporo, 060-8586, Japan.
Yutaka YamazakiGerodontology, Department of Oral Health Science, Faculty of Dental Medicine, Hokkaido University, Nishi 7-Tyoume Kita 13-Jyo, Kita-Ku, Sapporo, 060-8586, Japan.
Yoshimasa KitagawaDepartment of Oral Pathobiological Science, Faculty of Dental Medicine, Oral Diagnosis and Medicine, Hokkaido University, Nishi 7-Tyoume Kita 13-Jyo, Kita-Ku, Sapporo, 060-8586, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsBone NeoplasmsMultiple MyelomaOsteonecrosisDiphosphonatesHumansPrognosisBone Density Conservation AgentsDiphosphonates

Identifiers

PMID36318340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.